Generex Biotechnology Corporation has been working to develop a peptide vaccine against the new coronavirus SARS-CoV-2 using the company&rsquo;s proprietary and patented Ii-Key immune system activation technology.

Generex Biotechnology

Miramar

Generex Biotechnology startup from Miramar, United States is ranked 1366 out of 2449 worldwide and 498 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map